Related Experiment Video
Updated: May 14, 2026
09:46
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
[Demyelinating process in systematic rheumatoid diseases (review)]
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|February 5, 2013
Summary
Diagnosing neurological syndromes in young adults is challenging as multiple sclerosis (MS) and systemic rheumatic diseases (SRD) share similar symptoms and MRI findings. Differentiating these immune-mediated disorders requires further investigation due to a lack of specific diagnostic tools.
Area of Science:
- Neuroimmunology
- Rheumatology
- Demyelinating diseases
Context:
- Chronic immune-mediated disorders like multiple sclerosis (MS), systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), Sjogren's syndrome (SS), and Behcet disease (BD) affect young adults.
- The exact pathogenesis of these conditions remains largely unknown.
- Differentiating CNS involvement in MS from that in systemic rheumatic diseases (SRD) poses diagnostic challenges.
Purpose:
- To highlight the diagnostic difficulties in distinguishing MS from neurological manifestations of SRD.
- To underscore the challenge presented by acute, isolated neurological syndromes as potential early signs of various immune-mediated disorders.
- To emphasize the lack of specific diagnostic tools for these conditions.
Summary:
- Neurological presentations and MRI findings in MS and SRD can be indistinguishable.
- Acute isolated neurological syndromes are common in MS and can be the sole or initial manifestation of SLE, APS, SS, and BD.
- Current diagnostic methods lack specificity, complicating differential diagnosis.
Impact:
- Improved diagnostic strategies are needed for early and accurate identification of immune-mediated neurological disorders.
- This highlights a critical unmet need in neurology and rheumatology for better diagnostic tools.
- Understanding the overlap in presentation can lead to more comprehensive patient evaluation and management.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:21Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...